Roche is now marketing Vesanoid

January 1996

Roche is now marketing Vesanoid...in both the U.S. and Canada. It's the first vitamin A derivative to be approved for cancer.

Vesanoid is an oral form of tretinoin...the same ingredient that's in Retin-A.

Retinoids don't kill cancer cells like traditional chemo-therapy. Instead they help induce remission by getting immature cancer cells to differentiate and mature normally. These mature cells then die naturally.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote